Previous Article | Next Article ![]()
Journal of Clinical Microbiology, November 2001, p. 3823-3829, Vol. 39, No. 11
Molecular Biology Unit, Virus Reference
Division,1 and Campylobacter
Reference Unit, Laboratory of Enteric
Pathogens,2 Central Public Health Laboratory,
London NW9 5HT, United Kingdom
Received 8 June 2001/Returned for modification 30 July
2001/Accepted 16 August 2001
The published genome sequence of Campylobacter jejuni
strain NCTC 11168 was used to model an accurate and highly reproducible fluorescent amplified fragment length polymorphism (FAFLP) analysis. Predicted and experimentally observed amplified fragments (AFs) generated with the primer pair HindIII+A and
HhaI+A were compared. All but one of the 61 predicted AFs
were reproducibly detected, and no unpredicted fragments were
amplified. This FAFLP analysis was used to genotype 74 C. jejuni strains belonging to the nine heat-stable (HS) serotypes
most prevalent in human disease in England and Wales. The 74 C. jejuni strains exhibited 60 FAFLP profiles, and cluster analysis
of them yielded a radial tree showing genetic relationships between and
within 13 major clusters. Some clusters were related, and others were
unrelated, to a single HS serotype. For example, all strains belonging
to serotypes HS6 and HS19 grouped into corresponding single genotypic
clusters, while strains of serotypes HS11 and HS18 each grouped into
two genotypic clusters. Strains of HS50, the most prevalent serotype infecting humans, were found both in one large (multiserotype) cluster
complex and dispersed throughout the tree. The strain genotypes within
each FAFLP cluster were characterized by a particular combination of
AFs, and among the cluster there were additional differential AFs.
Identification of such AFs could act as a search tool to look for
potential associations with disease or animal hosts, when applied to
large number of human isolates. Genome-sequence based FAFLP, thus, has
the potential to establish a genetic database for epidemiological
investigations of Campylobacter.
Campylobacter is the
commonest cause of bacterial gastroenteritis in developed countries.
The incidence of human campylobacteriosis in England and Wales has
risen in recent years from ~34,000 cases reported to the Public
Health Laboratory Service Communicable Disease Surveillance Centre in
1990 to ~54,000 in 2000. It now surpasses the incidence of reported
salmonella infections 3.6-fold (information found at the website
http://www.phls.co.uk). Although most isolates are reported simply as
Campylobacter spp., available data suggest that over 90% of
campylobacters detected by culture belong to the species
Campylobacter jejuni. The next commonest species is
Campylobacter coli (10). Reproducible and
discriminatory typing methods are needed to identify the sources of
campylobacter infections, and to trace the routes of transmission of
strains through the food chain.
Phenotypic discrimination between isolates of C. jejuni and
C. coli uses serotyping of the heat stable (HS) (10,
24) or heat labile (16) surface-exposed antigens.
The two HS schemes both use antisera raised against the same type
strains but differ in their antigen detection methods. The method of
Penner and Hennessy (24) uses passive hemagglutination,
while the method of Frost et al. (10) employs direct
whole bacterial cell agglutination. Recent studies have shown the
existence of two distinct HS antigens in Campylobacter,
which may account for the differences in the two schemes. These
antigens are a polysaccharide capsule (3, 13) and a
lipopolysaccharide and/or lipooligosaccharide component of
the cell surface (17). The majority of C. jejuni isolates belong to only a limited number of HS serotypes,
and 19% of isolates are nontypeable with the current antiserum panel
using the direct agglutination method. Some of these limitations have
been addressed by employing phage typing (9) as an adjunct
to serotyping.
General drawbacks of these phenotypic typing methods are the restricted
availability, cost and quality of the antiserum reagents and phage
panels; cross-reactivity; and the level of nontypeability. These
factors have limited epidemiological studies of
Campylobacter, both nationally and globally
(26). Genotyping may therefore have a particularly
important role in studying the epidemiology of
Campylobacter, and a number of molecular methods have been applied and evaluated. They include flagellin gene (PCR-restriction fragment length polymorphism analysis) typing, pulsed-field gel electrophoresis (PFGE), random amplified polymorphic DNA, and ribotyping. The main features of and findings by these methods have
been reviewed by Wassenaar and Newell (26).
The genome-sampling technique of amplified fragment length polymorphism
(AFLP) analysis has been applied in empirical fashion to
Campylobacter spp., yielding promising new information based on percentage similarities of AFLP profiles, with regard to taxonomic relationships, genetic groupings, and outbreaks (7, 15,
20). Recently the complete C. jejuni genome sequence
(22) has been released, enabling us to apply to C. jejuni, for the first time, predictive modeling of fluorescent
AFLP (FAFLP) (1, 12).
The aim of the present study was to model FAFLP from the genome
sequence of C. jejuni strain NCTC 11168 and to validate the accuracy and reproducibility of this FAFLP by comparing predicted with
experimental AF sizes. We then used the standardized FAFLP analysis to
examine genotypic variation in relation to HS serotype for 74 C. jejuni isolates.
Bacterial strains, phenotypic typing, and culture
conditions.
The 74 strains of C. jejuni studied were
from samples of meat from retail outlets, unpasteurized milk, and human
fecal specimens from sporadic campylobacter infections. They belonged
to nine of the most prevalent HS serotypes isolated from humans in
England and Wales during 1998 and 1999 and belonged to various
phage types (PTs) (Table
1). One C. coli strain (strain 75 [Table 1]) isolated from a sample of
poultry meat was also included. The genome-sequenced strain NCTC 11168 (22) and the reference strains for six serotypes were also
included. All strains were HS serotyped using the direct agglutination
method and phage typed according to the standard protocols of the
Campylobacter Reference Unit (CRU) (Central Public Health Laboratory,
London, United Kingdom). Strains were cultured microaerobically
at 37°C for 48 h on blood agar plates and preserved for reference at
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.11.3823-3829.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Genome Sequence-Based Fluorescent Amplified Fragment Length
Polymorphism of Campylobacter jejuni, Its Relationship
to Serotyping, and Its Implications for Epidemiological
Analysis
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
80°C in Microbank cryovials (Pro-Lab Diagnostics, Cheshire, United
Kingdom).
TABLE 1.
Campylobacter jejuni isolate data
Standard nucleic acid extraction. Genomic DNA was extracted from 48-h Campylobacter plate cultures using the DNeasy tissue kit (Qiagen Ltd., Crawley, West Sussex, United Kingdom) according to the manufacturer's instructions. The concentration of DNA was estimated using a spectrophotometer (Beckman DU 640) by standard methods (25).
Computer methods. The complete genome sequence of C. jejuni NCTC 11168 (accession no. AL111168) was analyzed with Lasergene (DNAStar, Madison, Wis.) and MacVector (Oxford Molecular, Oxford, United Kingdom) software. Data for the sizes and number of fragments generated by HindIII and HhaI digestion were imported into a spreadsheet. These fragment sizes were then adjusted to allow the addition of primer sequence during PCR amplification.
FAFLP. FAFLP was performed on 500 ng of genomic DNA digested in a total volume of 30 µl, which consisted of 5 U of HindIII endonuclease (New England BioLabs [NEB], Hitchin, Hertfordshire, England), 3 µl of 10× NEB buffer 2, and 1.5 µl of DNase-free RNase A (10 µg/µl), for 1.5 h at 37°C. To this digest was then added 5 U of HhaI (NEB) and 0.3 µl of 100× bovine serum albumin (BSA), and the reactions were incubated for a further 1.5 h at 37°C. The endonucleases were inactivated (65°C for 10 min) prior to ligation.
To the double-digested DNA, 25 µl of a solution containing 0.5 µl of 2 µM HindIII adapter (Genosys Biotechnologies, Cambridge, United Kingdom), 0.5 µl of 20 µM HhaI adapter (Genosys Biotechnologies), 40 U of T4 DNA-ligase (NEB), and 5 µl of 10× T4 ligase buffer (NEB) was added. The reaction mixture was incubated at 16°C for 3 to 4 h, heated at 65°C for 10 min to inactivate the ligase, and stored at
20°C.
The sequence of the HindIII adapter was 5'-CTC GTA
GAC TGC GTA CC, 3'-CTG ACG CAT GGT CGA. The sequence of the HhaI adapter was 5'-GAC GAT GAG TCC TGA TCG, 3'-G CTA
CTC AGG ACT A. The forward primer (HindIII adaptor
specific), labeled with the blue fluorescent dye 5-carboxyfluorescein
(FAM), contained an extra selective base at the 3' end
(HindIII+A, 5'-GAC TGC GTA CCA GCT TA-3'
[Genosys Biotechnologies]) (7). The reverse primer (HhaI adapter specific) also contained an extra
selective base at the 3' end (HhaI+A, 5'-GAT GAG TCC
TGA TCG CA-3' [Genosys Biotechnologies]) (7). PCRs
were performed in 25-µl volumes containing 2.5 µl of ligated DNA,
2.0 µl of 1 µM FAM-labeled HindIII+A primer, 1.0 µl of 5.0 µM HhaI+A primer, 2.5 µl of 10×
Taq polymerase buffer (Life Technologies, Paisley, United
Kingdom), 1.25 µl of 50 mM MgCl2 (Life Technologies), 0.5 µl of 10 mM concentrations of each of the four deoxynucleoside
triphosphates (dNTPs) (Life Technologies), and 1.25 U of Taq
DNA polymerase (Life Technologies). Touchdown PCR cycling conditions
were as described previously (4, 5). FAFLP products were
separated on an ABI 377 automated DNA sequencer (Perkin-Elmer Corp.,
Norwalk, Conn.) using Premix Long Ranger 5% polyacrylamide gel
solution (FMC BioProducts, Vallensbaek Strand, Denmark) as described
previously (4, 5). Each FAFLP reaction (1 µl) was loaded
with an internal size marker (GeneScan-2500 labeled with the red
fluorescent dye 6-carboxy-x-rhodamine [ROX; PE Applied
Biosystems, Warrington, United Kingdom]). The running buffer was 1×
Tris-borate-EDTA (TBE), and the electrophoresis conditions were
2.0 kV at 51°C for 14 h. The well-to-read distance was 48 cm.
Fragment analysis. Fluorescent amplified fragments (AFs) visualized on polyacrylamide sequencing gels were sized with GeneScan 3.1.0 software (Perkin-Elmer Corp.). Gel displays were transformed into electropherograms, and Genotyper 2.5 software (Perkin-Elmer Corp.) was used to generate a table with presence or absence of fragments. Fragment data were recorded in a binary format in Excel (version 6.0; Microsoft). Dice coefficients of similarity were calculated with an in-house program. Cluster analysis was performed by UPGMA (NEIGHBOR program of PHYLIP) (8), and a dendrogram was displayed with the TreeView program (21).
| |
RESULTS |
|---|
|
|
|---|
Predictive modeling of FAFLP for the genome sequence of strain NCTC
11168 and its experimental validation.
When the complete genome
sequence of NCTC 11168 was analyzed (see Materials and Methods) to
predict the sizes of HindIII and HhaI
restriction fragments amplified by the primer pair
HindIII+A and HhaI+A (7), 61 AFs
were expected between 50 and 600 bp. The precision of sizing these AFs
was ±0.5 bp. Their positions in relation to the genetic loci on the
NCTC 11168 chromosome (22) are shown in Fig.
1. To determine the accuracy and
reproducibility of FAFLP for C. jejuni, three different DNA
preparations of strain NCTC 11168 were each subjected to three
different FAFLP reactions and run on individual sequencing gels. When
experimental data were compared with expected values, all but one
(sized 462 bp) of the predicted 61 AFs were observed in all nine of the
reactions, and no unpredicted fragments were amplified. Of the 60 AFs
observed, 36 were in the size range 55 to 300 bp; 35 of these were
within 1 bp and 1 was within 2 bp of the predicted size. Among the
remaining 24 AFs in the higher size range (300 to 600 bp), 9 AFs were
within 1 bp, 6 were within 2 bp, 8 were within 3 bp, and 1 was within 4 bp of the predicted size.
|
Strain genotyping by FAFLP analysis. The FAFLP profiles of the 75 strains analyzed in this study consisted of 45 to 100 AFs ranging in size from 60 to 600 bp; AFs larger than 600 bp were not included in our analysis. Sixty-one different FAFLP profiles were detected among the 75 strains, and 51 strains including NCTC 11168 and the C. coli strain had unique profiles. There were eight profiles which were shared by eight pairs of isolates each, including a pair of isolates from the same meat sample (isolates 9 and 10 [Table 1]). One profile was shared by three isolates, and another profile was shared by five isolates; these isolates sharing the same profile were from sporadic infections. Among all the 75 isolates, there were 231 polymorphic AFs (a polymorphic AF is here defined as one that is either uniquely present in a single profile or present in some profiles and absent in others). There were 182 polymorphic AFs among the 74 C. jejuni isolates.
Cluster analysis of FAFLP profiles and relationship to HS
serotype.
For each strain, AFs were sized (size calling tolerance
was ±0.5 bp) and scored as present (as 1) or absent (as 0) in a binary matrix. Cluster analysis was performed and a radial distance tree was
generated, on the basis of which FAFLP profiles were given genotype
designations (Fig. 2; Table 1). The
radial tree shows 13 major genotypic clusters (designated A-1 to A-6
and B to H in Fig. 2; Table 1). The isolates within all the 13 clusters showed
10% divergence. Cluster A complex (shown as a dotted line in
Fig. 2) was defined as such to reflect the serological relatedness of
its isolates (10) and constituted the genotypic clusters A-1 to A-6. The isolates within the cluster A complex exhibited
25%
genotypic divergence.
|
| |
DISCUSSION |
|---|
|
|
|---|
Human Campylobacter infections now greatly exceed Salmonella infections in incidence, but very few outbreaks have been linked to particular food sources (23). The frequent contamination of food by multiple strains has added to the difficulty of tracing the origins and routes of human infection and of recognizing outbreaks (14). Various phenotypic and genotypic methods have been applied in epidemiological studies of Campylobacter (18), but the question remains whether the recent large rise in C. jejuni infections reflects an increased incidence of sporadic infections or a number of outbreaks. In this study, we have standardized FAFLP to the genome sequence of C. jejuni NCTC 11168 (22) and experimentally validated this high-resolution genotyping technique using the published primer combination HindIII+A and HhaI+A, first defined in the novel empirical FAFLP studies of Duim and colleagues (7). We then investigated its use in reproducibly genotyping C. jejuni isolates.
The 60 experimentally recovered AFs (98% of the predicted AFs) derived from the NCTC 11168 strain represent approximately 1% of its total genome. The precision of sizing AFs was ±0.5 bp. Seventy-three percent of these AFs were within 1 bp of the predicted size. The accuracy of sizing was ±1 bp for AFs up to 300 bp but decreased to ±2 or 3 bp for AFs between 300 and 600 bp. AFs larger than 600 bp were not included in our analysis since the accuracy of sizing decreased further for larger fragments. The variation in sizing of >±1 bp can be attributed to the irregular spacing of bands in the ROX 2500 internal lane standard, and the use of more evenly spaced size markers would minimize this slight inaccuracy in AF sizing (data not shown). A few single base pair differences between pairs of predicted AFs (e.g., 97 and 98 bp and 104 and 105 bp) which could not be resolved by the ABI 377 sequencer presented as doublets on the electropherograms, both with higher signal strength. A few other identically sized AFs amplified from different regions of the genome (e.g., two of 117 bp and two of 237 bp) appeared either as broader peaks on the trace with a higher signal strength (e.g., the 117-bp AF) or as two AFs 1 bp apart.
Among the 74 isolates of C. jejuni examined in this study, seven AFs were common to all genotypes. This finding is being further investigated in our laboratory, with a view to sequencing AFs which have potential in molecular identification assays, e.g., in DNA arrays. The identification of AFs such as these also shows that FAFLP could act as a powerful search tool when used to screen large numbers of isolates from human disease. Clearly, there is a potential application in searching clinical microbiology FAFLP databases for as-yet-unidentified associations with host specificity and specific differential AFs.
Dingle et al. (6) examined the genetic variation present in seven housekeeping genes of C. jejuni by multilocus sequence typing (MLST). In a strain collection comprising 194 diverse C. jejuni strains from humans, animals, and the environment, they found 155 sequence types (STs) comprising 11 clone complexes and 51 unique STs. One of the largest MLST lineages, the ST-21 complex, predominantly comprised strains of the Penner HS serotypes Pen1, Pen2, and Pen4 and included NCTC 11168. The most commonly encountered HS serotypes in England and Wales include Pen1, Pen2, and Pen44 as serotyped by passive hemagglutination (24), or HS1, HS2, HS44, and HS50 as serotyped by direct agglutination (10). This group of serotypes can therefore be related to the FAFLP cluster A complex. Since our FAFLP cluster A complex included strain NCTC 11168 and comprised multiple isolates from serotypes HS2, HS16, HS44, and HS50, it is likely to correspond to or overlap with the MLST lineage ST-21. By the same reasoning, FAFLP cluster F, comprising strains of serotype HS19, can be related to MLST lineage ST-22. These conclusions are in line with the previously published congruencies of FAFLP with either MLST or multilocus enzyme electrophoresis (2, 11). Olive and Bean (19), in a recently published comparison of various DNA-based typing methods of bacterial organisms, estimate the costs for a single FAFLP reaction at $20 and that for seven-locus MLST of a single strain at $280. In our view, FAFLP exhibits superior cost-effectiveness, adaptability, discriminatory power, and ease of use. Nonetheless the two methods can be described as complementary because, both being based on the genome sequence, they are theoretically as well as experimentally congruent.
Serotype HS50 is the most prevalent serotype among C. jejuni strains isolated from humans, and it accounts for approximately 20% of all infections. The FAFLP data presented here indicate that this serotype is genetically heterogeneous. Although nine HS50 strains were found in the multiserotype cluster A complex and two strains were found in cluster G, there was no congruence between FAFLP genotypes and serotype for the remaining five HS50 strains included in the study. Strains belonging to serotypes HS11 and HS18 grouped into two separate genotypic clusters each. In contrast, all strains belonging to serotypes HS19 and HS6 grouped into serotype-specific clusters, indicating the genetic homogeneity of these two serotypes. The lack of congruence between FAFLP genotypes and certain serotypes and between FAFLP genotypes and sero-phage types of C. jejuni indicates that further investigative genotyping of this major enteropathogen will define its epidemiological clonality more accurately.
We have also demonstrated that FAFLP defines strain genotypes within and between clusters by unique combinations of precisely sized marker AFs. These AFs could serve as identification markers ("bar codes") that define clonality and could be used as the basis of a molecular typing scheme. A continuously updated radial tree such as that shown in Fig. 2 could, in effect, serve as a genetic record of strain genotypes. The genetic data could then be linked in a comprehensive database with epidemiological information and phenotyping data, to facilitate the identification of outbreaks and sources of apparently sporadic human infection.
We conclude that FAFLP is a highly reproducible method for typing C. jejuni (as demonstrated with the NCTC 11168 strain), capable of recognizing genotypic clusters. These FAFLP genotypic clusters were not congruent with all HS serotypes. Within genotypic clusters, FAFLP could readily distinguish between individual strains. We expect FAFLP to become a powerful tool in the macro- and microepidemiological analysis of campylobacter incidence, including outbreak investigations. It could also be used to establish a genetic database of strains drawn from across the food chain and human cases.
| |
ACKNOWLEDGMENTS |
|---|
We thank Richard Thwaites and Judith Richardson for providing the strains and epidemiological data and Philip Mortimer and Henry Smith for critically reading the manuscript.
This work was partly supported by a grant (B03014) from the Food Standards Agency, London, United Kingdom.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Molecular Biology Unit, Virus Reference Division, Central Public Health Laboratory, 61 Colindale Ave., London NW9 5HT, United Kingdom. Phone: 0208 200 4400, ext. 3072. Fax: 0208 200 1569. E-mail: mdesai{at}phls.org.uk.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Arnold, C., L. Metherell, J. P. Clewley, and J. Stanley. 1999. Predictive modelling of fluorescent AFLP: a new approach to the molecular epidemiology of E. coli. Res. Microbiol. 150:33-44[Medline]. |
| 2. |
Arnold, C.,
L. Metherell,
G. Willshaw,
A. Maggs, and J. Stanley.
1999.
Predictive fluorescent amplified-fragment length polymorphism analysis of Escherichia coli: high-resolution typing method with phylogenetic significance.
J. Clin. Microbiol.
37:1274-1279 |
| 3. | Chart, H., J. A. Frost, A. Oza, R. Thwaites, S. Gillanders, and B. Rowe. 1996. Heat-stable serotyping antigens expressed by strains of Campylobacter jejuni are probably capsular and not long-chain lipopolysaccharide. J. Appl. Bacteriol. 81:635-640[Medline]. |
| 4. |
Desai, M.,
A. Efstratiou,
R. George, and J. Stanley.
1999.
High-resolution genotyping of Streptococcus pyogenes serotype M1 isolates by fluorescent amplified-fragment length polymorphism analysis.
J. Clin. Microbiol.
37:1948-1952 |
| 5. |
Desai, M.,
A. Tanna,
R. Wall,
A. Efstratiou,
R. George, and J. Stanley.
1998.
Fluorescent amplified-fragment length polymorphism analysis of an outbreak of group A streptococcal invasive disease.
J. Clin. Microbiol.
36:3133-3137 |
| 6. |
Dingle, K. E.,
F. M. Colles,
D. R. Wareing,
R. Ure,
A. J. Fox,
F. E. Bolton,
H. J. Bootsma,
R. J. Willems,
R. Urwin, and M. C. Maiden.
2001.
Multilocus sequence typing system for Campylobacter jejuni.
J. Clin. Microbiol.
39:14-23 |
| 7. |
Duim, B.,
C. W. Ang,
A. van Belkum,
A. Rigter,
N. W. J. van Leeuwen,
H. P. Endtz, and J. A. Wagenaar.
2000.
Amplified fragment length polymorphism analysis of Campylobacter jejuni strains isolated from chickens and from patients with gastroenteritis or Guillain-Barré or Miller Fisher syndrome.
Appl. Environ. Microbiol.
66:3917-3923 |
| 8. |
Felsenstein, J.
1989.
PHYLIP Phylogeny Inference Package.
Cladistics
5:164-166.
|
| 9. | Frost, J. A., J. M. Kramer, and S. A. Gillanders. 1999. Phage typing of Campylobacter jejuni and Campylobacter coli and its use as an adjunct to serotyping. Epidemiol. Infect. 123:47-55[CrossRef][Medline]. |
| 10. |
Frost, J. A.,
A. N. Oza,
R. T. Thwaites, and B. Rowe.
1998.
Serotyping scheme for Campylobacter jejuni and Campylobacter coli based on direct agglutination of heat-stable antigens.
J. Clin. Microbiol.
36:335-339 |
| 11. |
Goulding, J. N.,
J. V. Hookey,
J. Stanley,
W. Olver,
K. R. Neal,
D. A. Ala'Aldeen, and C. Arnold.
2000.
Fluorescent amplified-fragment length polymorphism genotyping of Neisseria meningitidis identifies clones associated with invasive disease.
J. Clin. Microbiol.
38:4580-4585 |
| 12. |
Goulding, J. N.,
J. Stanley,
N. Saunders, and C. Arnold.
2000.
Genome-sequence-based fluorescent amplified-fragment length polymorphism analysis of Mycobacterium tuberculosis.
J. Clin. Microbiol.
38:1121-1126 |
| 13. | Karlyshev, A. V., D. Linton, N. A. Gregson, A. J. Lastovica, and B. W. Wren. 2000. Genetic and biochemical evidence of a Campylobacter jejuni capsular polysaccharide that accounts for Penner serotype specificity. Mol. Microbiol. 35:529-541[CrossRef][Medline]. |
| 14. | Kramer, J. M., J. A. Frost, F. J. Bolton, and D. R. Wareing. 2000. Campylobacter contamination of raw meat and poultry at retail sale: identification of multiple types and comparison with isolates from human infection. J. Food Protect. 63:1654-1659[Medline]. |
| 15. |
Lindstedt, B. A.,
E. Heir,
T. Vardund,
K. K. Melby, and G. Kapperud.
2000.
Comparative fingerprinting analysis of Campylobacter jejuni subsp. jejuni strains by amplified-fragment length polymorphism genotyping.
J. Clin. Microbiol.
38:3379-3387 |
| 16. |
Lior, H.,
D. L. Woodward,
J. A. Edgar,
L. J. Laroche, and P. Gill.
1982.
Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors.
J. Clin. Microbiol.
15:761-768 |
| 17. | Moran, A. P., and J. L. Penner. 1999. Serotyping of Campylobacter jejuni based on heat-stable antigens: relevance, molecular basis and implications in pathogenesis. J. Appl. Microbiol. 86:361-377[CrossRef][Medline]. |
| 18. |
Nielsen, E. M.,
J. Engberg,
V. Fussing,
L. Petersen,
C. H. Brogren, and S. L. On.
2000.
Evaluation of phenotypic and genotypic methods for subtyping Campylobacter jejuni isolates from humans, poultry, and cattle.
J. Clin. Microbiol.
38:3800-3810 |
| 19. |
Olive, D. M., and P. Bean.
1999.
Principles and applications of methods for DNA-based typing of microbial organisms.
J. Clin. Microbiol.
37:1661-1669 |
| 20. | On, S. L., and C. S. Harrington. 2000. Identification of taxonomic and epidemiological relationships among campylobacter species by numerical analysis of AFLP profiles. FEMS Microbiol. Lett. 193:161-169[CrossRef][Medline]. |
| 21. |
Page, R. D.
1996.
TreeView: an application to display phylogenetic trees on personal computers.
Comput. Appl. Biosci.
12:357-358 |
| 22. | Parkhill, J., B. W. Wren, K. Mungall, J. M. Ketley, C. Churcher, D. Basham, T. Chillingworth, R. M. Davies, T. Feltwell, S. Holroyd, K. Jagels, A. V. Karlyshev, S. Moule, M. J. Pallen, C. W. Penn, M. A. Quail, M. A. Rajandream, K. M. Rutherford, A. H. van Vliet, S. Whitehead, and B. G. Barrell. 2000. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403:665-668[CrossRef][Medline]. |
| 23. | Pebody, R. G., M. J. Ryan, and P. G. Wall. 1997. Outbreaks of campylobacter infection: rare events for a common pathogen. Commun. Dis. Rep. Rev. 7:R33-R37. |
| 24. |
Penner, J. L., and J. N. Hennessy.
1980.
Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens.
J. Clin. Microbiol.
12:732-737 |
| 25. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 26. | Wassenaar, T. M., and D. G. Newell. 2000. Genotyping of Campylobacter spp. J. Appl. Bacteriol. 66:1-9. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|